Future studies using human NSCLC specimens are warranted to compare various factors, such as the amount, density, and type of tumor-infiltrating immune cells, clinical factors (including smoking history), genetic mutations of cancer cells, estrogen levels, and ER expression, to elucidate the influence of estrogen on tumor immunity in NSCLC. Here, ESR1 is linked to non-small cell lung carcinoma.